95 related articles for article (PubMed ID: 25377471)
1. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
[TBL] [Abstract][Full Text] [Related]
2. Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.
Cianfrocca R; Tocci P; Rosanò L; Caprara V; Sestito R; Di Castro V; Bagnato A
Oncotarget; 2016 Apr; 7(14):17790-804. PubMed ID: 26909598
[TBL] [Abstract][Full Text] [Related]
3. miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.
Sestito R; Cianfrocca R; Rosanò L; Tocci P; Semprucci E; Di Castro V; Caprara V; Ferrandina G; Sacconi A; Blandino G; Bagnato A
Oncotarget; 2016 Jan; 7(4):4009-23. PubMed ID: 26675258
[TBL] [Abstract][Full Text] [Related]
4. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK.
Masi I; Caprara V; Spadaro F; Chellini L; Sestito R; Zancla A; Rainer A; Bagnato A; Rosanò L
Cell Rep; 2021 Mar; 34(9):108800. PubMed ID: 33657382
[TBL] [Abstract][Full Text] [Related]
6. CCT2 prevented β-catenin proteasomal degradation to sustain cancer stem cell traits and promote tumor progression in epithelial ovarian cancer.
Chen J; Hu Q; Zhou C; Jin D
Mol Biol Rep; 2024 Jan; 51(1):54. PubMed ID: 38165547
[TBL] [Abstract][Full Text] [Related]
7. [Study of the clinical significance of ETAR mRNA expression in high-grade serous ovarian cancer and the inhibitory effect of ETAR derived fusion polypeptide on cancer progression].
Zhang YL; Xia XK; Zhang M
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):930-938. PubMed ID: 38123199
[No Abstract] [Full Text] [Related]
8. USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway.
Pei L; Zhao F; Zhang Y
Apoptosis; 2024 Feb; 29(1-2):210-228. PubMed ID: 38087046
[TBL] [Abstract][Full Text] [Related]
9. Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.
Cismas S; Pasca S; Crudden C; Trocoli Drakensjo I; Suleymanova N; Zhang S; Gebhard B; Song D; Neo S; Shibano T; Smith TJ; Calin GA; Girnita A; Girnita L
Mol Cancer Res; 2023 Dec; 21(12):1288-1302. PubMed ID: 37584671
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Endothelin-1 pathway to reduce invasion and chemoresistance in gallbladder cancer cells.
Rodas F; Vidal-Vidal JA; Herrera D; Brown-Brown DA; Vera D; Veliz J; Püschel P; Erices JI; Sánchez Hinojosa V; Tapia JC; Silva-Pavez E; Quezada-Monrás C; Mendoza-Soto P; Salazar-Onfray F; Carrasco C; Niechi I
Cancer Cell Int; 2023 Dec; 23(1):318. PubMed ID: 38072958
[TBL] [Abstract][Full Text] [Related]
11. Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probes.
Delahaye J; Stölting M; Geyer C; Vogl T; Eisenblätter M; Helfen A; Höltke C
Eur J Med Chem; 2023 Oct; 258():115568. PubMed ID: 37379676
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Localization of Endothelin- 1 and Endothelin A Receptor in Human Primary Tooth Enamel Organ.
Irani S; Alimohammadi S; Najafian T
J Dent (Shiraz); 2023 Sep; 24(3):328-334. PubMed ID: 37727358
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer.
Ryu JW; Shin HY; Kim HS; Han GH; Kim JW; Lee HN; Cho H; Chung JY; Kim JH
Front Oncol; 2023; 13():1104521. PubMed ID: 36969037
[TBL] [Abstract][Full Text] [Related]
14. Adaptation to volumetric compression drives hepatoblastoma cells to an apoptosis-resistant and invasive phenotype.
Gong X; Ogino N; Leite MF; Chen Z; Nguyen R; Liu R; Kruglov E; Flores K; Cabral A; Mendes GMM; Ehrlich BE; Mak M
bioRxiv; 2023 Oct; ():. PubMed ID: 37873476
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 and Its Role in Cancer and Potential Therapeutic Opportunities.
Harrison M; Zinovkin D; Pranjol MZI
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540124
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin-driven EMT regulation in human cancers.
Xue W; Yang L; Chen C; Ashrafizadeh M; Tian Y; Sun R
Cell Mol Life Sci; 2024 Feb; 81(1):79. PubMed ID: 38334836
[TBL] [Abstract][Full Text] [Related]
17. Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia.
Wang H; Qiu Y; Zhang H; Chang N; Hu Y; Chen J; Hu R; Liao P; Li Z; Yang Y; Cen Q; Ding X; Li M; Xie X; Li Y
Cell Death Dis; 2023 Aug; 14(8):498. PubMed ID: 37542030
[TBL] [Abstract][Full Text] [Related]
18. SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer.
Xu QP; Deng K; Zhang Z; Shang H
J Ovarian Res; 2023 Feb; 16(1):33. PubMed ID: 36747204
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition.
Tocci P; Roman C; Sestito R; Di Castro V; Sacconi A; Molineris I; Paolini F; Carosi M; Tonon G; Blandino G; Bagnato A
Cell Death Dis; 2023 Jan; 14(1):5. PubMed ID: 36604418
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer.
Zmarzły N; Januszyk S; Mieszczański P; Morawiec E; Buda P; Dziobek K; Opławski M; Boroń D
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5687-5696. PubMed ID: 36542159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
